Cargando…
Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19
Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infe...
Autor principal: | Samet, Jonathan M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953960/ https://www.ncbi.nlm.nih.gov/pubmed/33320258 http://dx.doi.org/10.1093/ntr/ntaa187 |
Ejemplares similares
-
Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
por: McCullough, Peter A.
Publicado: (2020) -
When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022) -
Africa’s contribution to the science of the COVID-19/SARS-CoV-2 pandemic
por: Kana, Musa Abubakar, et al.
Publicado: (2021) -
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021) -
Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)